Prasad S Adusumilli
Overview
Explore the profile of Prasad S Adusumilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
323
Citations
8485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avutu V, Algazaq J, Seier K, Desir-Camille R, Qin L, Babatunde O, et al.
Transplant Cell Ther
. 2025 Feb;
PMID: 39993596
Adoptive cellular therapy (ACT) is an increasingly widely used treatment approach for malignancy. While infectious complications of ACT have been well described in patients with hematologic malignancies, limited data are...
2.
Nadig T, Dave J, Adusumilli P, Bott M, Chawla M, Gray K, et al.
Respir Med
. 2025 Jan;
238:107963.
PMID: 39870145
No abstract available.
3.
Agrawal P, Offin M, Lai V, Ginsberg M, Adusumilli P, Rusch V, et al.
JTO Clin Res Rep
. 2025 Jan;
6(1):100756.
PMID: 39802820
Introduction: WT1 often presents on the surface of diffuse pleural mesotheliomas (DPMs) and is an ideal therapeutic target. Galinpepimut-S (GPS), a tetravalent, non-human leukocyte antigen-restricted, heteroclitic WT1-specific peptide vaccine was...
4.
Fanaroff R, Yang S, Tan K, Adusumilli P, Bodd F, Bowman A, et al.
Mod Pathol
. 2025 Jan;
38(5):100706.
PMID: 39788204
Histologic features, including architectural patterns, cytologic features, and 2021 World Health Organization nuclear grade have been shown to have prognostic significance in epithelioid diffuse pleural mesothelioma (DPM). Biphasic and sarcomatoid...
5.
Dunne E, Fick C, Mastrogiacomo B, Tan K, Toumbacaris N, Vanstraelen S, et al.
JTCVS Open
. 2025 Jan;
22():458-469.
PMID: 39780816
Objective: To identify clinicopathologic and genomic features associated with brain metastasis after resection of lung adenocarcinoma (LUAD) and to evaluate survival after brain metastasis. Methods: Patients who underwent complete resection...
6.
Sewell M, Boerner T, Harrington C, Hsu M, Tan K, Carr R, et al.
Ann Surg
. 2025 Jan;
PMID: 39774469
Objective: Evaluate an electronic platform for remote symptom monitoring to enhance postdischarge care in thoracic surgery using patient reporting of symptoms. Summary Background Data: Owing to the increased use of...
7.
Ripley R, Adusumilli P, Bograd A, Bolukbas S, Bueno R, Cameron R, et al.
J Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39675416
No abstract available.
8.
Misawa K, Bhat H, Adusumilli P, Hou Z
Pharmacol Ther
. 2024 Dec;
266:108763.
PMID: 39617146
Chimeric antigen receptor (CAR) T-cell therapy has achieved potent antitumor efficacy in hematological malignancies; however, because of limitations in CAR T-cell recruitment, infiltration, activation, and functional persistence in the tumor,...
9.
Cranwell V, Adusumilli P
Ann Thorac Surg
. 2024 Nov;
118(6):1205-1206.
PMID: 39581671
No abstract available.
10.
Bellis R, Cranwell V, Adusumilli P
J Thorac Cardiovasc Surg
. 2024 Nov;
PMID: 39486509
No abstract available.